Pro Medicus Limited (ASX:PME)
Australia flag Australia · Delayed Price · Currency is AUD
164.11
-0.44 (-0.27%)
Jun 16, 2026, 4:10 PM AEST

Pro Medicus Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Pro Medicus stock has a consensus rating of "Buy" and an average price target of $180.44. The average 1-year stock price forecast is 9.95% higher than the current stock price, while the lowest is $54.00 (-67.10%) and the highest is $245.00 (+49.29%).

Price Target: $180.44 (+9.95%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$54.00$180.44$197.00$245.00
Change-67.10%+9.95%+20.04%+49.29%

Analyst Ratings

The average analyst rating for Pro Medicus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy567799
Buy322333
Hold543322
Sell000000
Strong Sell111111
Total141313141515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Macquarie
No rating
Macquarie
Buy
Maintains
$221.00
BuyMaintains$221.00+34.67%Jun 2, 2026
Morgans
Morgans
Buy
Maintains
$210.00
BuyMaintains$210.00+27.96%Jun 2, 2026
RBC Capital
RBC Capital
Hold
Maintains
$195.00
HoldMaintains$195.00+18.82%Jun 1, 2026
Jefferies
Jefferies
Buy
Maintains
$147.00
BuyMaintains$147.00-10.43%May 25, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$207.90
BuyMaintains$207.90+26.68%May 19, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
261.66M
from 212.98M
Increased by 22.86%
Revenue Next Year
334.02M
from 261.66M
Increased by 27.66%
EPS This Year
1.37
from 1.14
Increased by 19.95%
EPS Next Year
1.80
from 1.37
Increased by 31.99%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
68.06M93.46M124.90M161.50M212.98M261.66M
Revenue Growth
19.79%37.31%33.64%29.30%31.87%22.86%
Gross Profit
67.57M93.00M124.36M161.20M212.67M260.68M
Gross Margin
99.28%99.50%99.56%99.81%99.85%99.63%
Operating Income
42.63M61.31M84.08M112.79M157.79M214.84M
Net Income
30.85M44.44M60.65M82.79M115.22M242.62M
EPS
----1.141.37
EPS Growth
----49.48%19.95%
Forward PE
151.3882.65100.34151.89203.41120.13
Dividend / Share
0.150.220.300.400.550.82
Dividend Growth
-46.67%36.36%33.33%37.50%49.58%
Free Cash Flow
24.00M42.34M46.18M69.20M91.53M132.18M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202620272028
High278.4M
Avg261.7M
Low252.8M

Revenue Growth

Revenue Growth202620272028
High
30.7%
Avg
22.9%
Low
18.7%

EPS Forecast

EPS202620272028
High1.45
Avg1.37
Low1.30

EPS Growth

EPS Growth202620272028
High
27.4%
Avg
20.0%
Low
14.1%